Wednesday, May 3, 2017

BRIEF-Theratechnologies partner Taimed submits biologics license application for Ibalizumab

* Theratechnologies partner submits biologics license

application for HIV Monoclonal Antibody and long-acting

investigational antiretroviral Ibalizumab

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)